High-dose radiation for prostate cancer return after surgery
Part of Cancer, Kidney & urinary clinical trials.
This trial tests a high-dose radiation treatment (brachytherapy) that places tiny radioactive seeds directly into the area where your prostate was. It is for men whose prostate cancer has returned only in that area after having their prostate removed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your PSA level must have been going up after your prostate was removed.
- PET and MRI scans must show that the cancer is only in the area where your prostate used to be (the prostate bed).
- The cancer spot must be visible on a transrectal ultrasound so the doctor can guide the treatment needles.
- The cancer must not have spread to other parts of your body (no distant metastases).
- You must be healthy enough to tolerate the procedure and have a life expectancy of at least 5 years.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a precise radiation treatment for prostate cancer that uses MRI images to guide the radiation beams. It may be an option for men with higher-risk prostate cancer who can have an MRI and have not had radiation before.
This trial studies high-dose radiation (HDR) given after prostate cancer returns only in the prostate/seminal vesicles. It may help by trying to control the cancer when it has not spread elsewhere, using targeted treatment based on MRI and biopsy proof.
This trial tests a new way to use a type of internal radiation (high-dose-rate brachytherapy) guided by MRI to treat prostate cancer that has come back in the same area after previous radiation therapy. It is designed to be more precise and hopefully safer while using the latest PSMA PET scans to make sure the cancer hasn't spread.
This study tests a focused (“salvage”) brachytherapy—radiation placed directly near the prostate—to treat prostate cancer that has returned after earlier radiation. It may help control the tumor while limiting radiation exposure to surrounding tissues, based on how well people fit the study’s safety and cancer details.
This trial tests a focused form of radiation placed inside the prostate to treat only the cancer area in people with low-risk prostate cancer. It aims to control the cancer while limiting treatment to a smaller area.
This trial studies how safe and effective different high-dose radiation levels are for prostate cancer placed directly in the prostate (HDR brachytherapy). It may help by finding a dose that controls the cancer while keeping side effects acceptable.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.